Emergent BioSolutions Inc.EBSNYSE
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR-22.7%
Studio
Year-over-Year Change

Year-over-year net income growth rate

5Y CAGR
-22.7%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025127.60%
202474.94%
2023-259.40%
2022-196.40%
2021-28.22%
2020461.10%
2019-13.08%
2018-24.09%
201759.46%
2016-17.61%